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Introduction {#embr201948101-sec-0001}
============

Mitochondria harbor the oxidative phosphorylation (OXPHOS) system, which performs cellular energy conversion resulting in the production of adenosine triphosphate (ATP) [1](#embr201948101-bib-0001){ref-type="ref"}, [2](#embr201948101-bib-0002){ref-type="ref"}. Deficient OXPHOS is a well‐established primary cause of mitochondrial disease and is also secondarily implicated in a variety of pathophysiological conditions, such as neurological disease, age‐related diseases, and aging [3](#embr201948101-bib-0003){ref-type="ref"}. The regulation of OXPHOS is complex because subunits of the respiratory chain and the ATP synthase are encoded by both the nuclear genome and mtDNA [4](#embr201948101-bib-0004){ref-type="ref"}, [5](#embr201948101-bib-0005){ref-type="ref"}.

Mammalian mtDNA is a gene‐dense, circular double‐stranded DNA molecule, and the two strands are defined as the heavy (H) and the light (L) strand according to their base composition [6](#embr201948101-bib-0006){ref-type="ref"}. The mtDNA only encodes 13 of the ∼90 proteins present in the OXPHOS system, but all of these are essential subunits [4](#embr201948101-bib-0004){ref-type="ref"}, [5](#embr201948101-bib-0005){ref-type="ref"}. In addition, mtDNA encodes 2 ribosomal RNAs (mt‐rRNAs) and 22 transfer RNAs (mt‐tRNAs), which are necessary for translation of mitochondrial mRNAs (mt‐mRNAs). The compact mtDNA only contains one longer noncoding region named the displacement loop (D‐loop), where the origin of replication of the H strand (O~H~) and the promoters for transcription of H and L strands (HSP and LSP) are located [7](#embr201948101-bib-0007){ref-type="ref"}, [8](#embr201948101-bib-0008){ref-type="ref"}.

Transcription of mtDNA initiates from HSP and LSP and generates two, near genomic‐length polycistronic precursor RNAs, which sequentially go through processing to yield individual mitochondrial RNAs (mtRNAs) [5](#embr201948101-bib-0005){ref-type="ref"}. Transcription initiation has been extensively studied using *in vitro* and *in vivo* models, showing that the mitochondrial RNA polymerase (POLRMT) and mitochondrial transcription factors A (TFAM) and B2 (TFB2M) are core components in this process [9](#embr201948101-bib-0009){ref-type="ref"}, [10](#embr201948101-bib-0010){ref-type="ref"}, [11](#embr201948101-bib-0011){ref-type="ref"}. In brief, TFAM unwinds the promoter region of double‐stranded DNA (dsDNA) and introduces a transcription bubble covering the initiation site. This loose structure is essential for the recruitment of POLRMT and enables TFB2M binding, which completes the assembly of the initiation complex [12](#embr201948101-bib-0012){ref-type="ref"}, [13](#embr201948101-bib-0013){ref-type="ref"}. However, once POLRMT successfully transcribes the promoter region, TFB2M is released from the initiation complex [14](#embr201948101-bib-0014){ref-type="ref"}, [15](#embr201948101-bib-0015){ref-type="ref"}. Thus, TFB2M is necessary for transcription initiation, but not for elongation. Recent studies have also identified and characterized TEFM as another component of the mitochondrial transcription machinery that interacts with POLRMT and promotes transcription processivity to enable near genome‐length transcription [16](#embr201948101-bib-0016){ref-type="ref"}, [17](#embr201948101-bib-0017){ref-type="ref"}. The structures of the transcription initiation [18](#embr201948101-bib-0018){ref-type="ref"} and elongation complexes [19](#embr201948101-bib-0019){ref-type="ref"} have recently been determined. Binding of TEFM to POLRMT allows the complex to form a "sliding clamp" around the DNA, which facilitates high processivity of transcription [19](#embr201948101-bib-0019){ref-type="ref"}. TEFM also enhances POLRMT transcription by reducing the duration and frequencies of long‐lived transcription pauses [20](#embr201948101-bib-0020){ref-type="ref"}.

Transcription initiated from LSP also supplies primers for the replication of mtDNA. Using a recombinant *in vitro* transcription system, previous studies have suggested that a large proportion of transcription events initiated at LSP are prematurely terminated at the conserved sequence block II (CSBII) within the D‐loop region [21](#embr201948101-bib-0021){ref-type="ref"}. This termination occurs because of the formation of a G‐quadruplex structure between nascent RNA and the non‐template strand of mtDNA and has been proposed to be linked to primer formation for initiation of H‐strand DNA replication [22](#embr201948101-bib-0022){ref-type="ref"}, [23](#embr201948101-bib-0023){ref-type="ref"}. The newly transcribed RNA remains associated with the CSB region, where it forms an R‐loop that is resistant to treatment by RNase A and RNase T1 [24](#embr201948101-bib-0024){ref-type="ref"}, [25](#embr201948101-bib-0025){ref-type="ref"}, [26](#embr201948101-bib-0026){ref-type="ref"}. Interestingly, TEFM has been reported to regulate the generation of replication primers in human mitochondria [27](#embr201948101-bib-0027){ref-type="ref"} by helping POLRMT to bypass the highly structured CSBII region [19](#embr201948101-bib-0019){ref-type="ref"}, [20](#embr201948101-bib-0020){ref-type="ref"} and abolish R‐loop formation [17](#embr201948101-bib-0017){ref-type="ref"}. Results from an *in vitro* study have been interpreted to support a model where TEFM serves as a molecular switch that coordinates the balance between mtDNA transcription for replication primer formation and gene expression [27](#embr201948101-bib-0027){ref-type="ref"}, whereas another *in vitro* study argues that TEFM is a general unspecific transcription elongator needed for mtDNA gene expression [17](#embr201948101-bib-0017){ref-type="ref"}.

Processing of the newly synthesized polycistronic precursor RNAs to release mature mtRNAs is thought to occur co‐transcriptionally and is mainly performed in distinct foci, named mitochondrial RNA granules [28](#embr201948101-bib-0028){ref-type="ref"}, [29](#embr201948101-bib-0029){ref-type="ref"}, [30](#embr201948101-bib-0030){ref-type="ref"}. The RNA granules provide an organizational platform for spatiotemporal regulation of mitochondrial RNA processing and maturation [31](#embr201948101-bib-0031){ref-type="ref"}. The majority of mt‐rRNAs and mt‐mRNAs are flanked by mt‐tRNAs and processing starts with the excision of these flanking mt‐tRNAs, according to the widely accepted tRNA punctuation model [32](#embr201948101-bib-0032){ref-type="ref"}. The endonucleolytic cleavage of the 5′‐ and 3′‐ends of the tRNAs is performed by the mitochondrial RNase P complex, which consists of MRPP1, MRPP2, and MRPP3 [33](#embr201948101-bib-0033){ref-type="ref"}, [34](#embr201948101-bib-0034){ref-type="ref"} and the mitochondrial RNase Z (ELAC2) [35](#embr201948101-bib-0035){ref-type="ref"}, [36](#embr201948101-bib-0036){ref-type="ref"}, respectively, situated in close proximity to the RNA granules [29](#embr201948101-bib-0029){ref-type="ref"}, [37](#embr201948101-bib-0037){ref-type="ref"}. The G‐rich RNA sequence binding factor 1 (GRSF1) can melt dsRNA [38](#embr201948101-bib-0038){ref-type="ref"} and is localized in RNA granules where it interacts with RNase P [29](#embr201948101-bib-0029){ref-type="ref"}, [30](#embr201948101-bib-0030){ref-type="ref"}. Other processing factors are also present in the RNA granules, such as the Fas‐activated serine/threonine kinase (FASTK) protein family members FASTK, FASTK2 and FASTKD5 [39](#embr201948101-bib-0039){ref-type="ref"}, [40](#embr201948101-bib-0040){ref-type="ref"}, the mitochondrial poly(A)‐polymerase (mtPAP) [41](#embr201948101-bib-0041){ref-type="ref"}, methyltransferases [42](#embr201948101-bib-0042){ref-type="ref"}, RNA helicases, and the degradosome (SUPV3L1‐PNPase) complex [43](#embr201948101-bib-0043){ref-type="ref"}.

In this study, we have established the *in vivo* function of TEFM by generating and characterizing conditional *Tefm*‐knockout mice. We report that TEFM is essential for embryonic survival and that loss of TEFM in the mouse heart causes mitochondrial cardiomyopathy with severe OXPHOS deficiency. Depletion of TEFM drastically reduces the levels of promoter‐distal transcripts encoded by both mtDNA strands. In contrast, there is a marked increase in the steady‐state levels of promoter‐proximal transcripts at both LSP and HSP in the absence of TEFM. At LSP, these short transcripts are prematurely terminated and shorter than the RNA primers needed for initiation of mtDNA replication. Consistently, *de novo* mtDNA replication is drastically decreased in isolated mitochondria lacking TEFM. Unexpectedly, RNA sequencing (RNA‐Seq) and northern blot analyses show that there is an increase of unprocessed mitochondrial transcripts in the absence of TEFM. TEFM proximity‐labeling (BioID) assays show that TEFM interacts with diverse RNA processing factors, including the RNase P complex (MRPP1‐3), ELAC2, GRSF1, and SUPV3L1‐PNPase, which may explain why transcription elongation affects RNA processing. Our results thus show that TEFM is necessary for transcription of mtDNA to generate both short replication primers and near genome‐length transcripts for gene expression. Furthermore, we show that loss of TEFM affects both transcription elongation and RNA processing *in vivo*.

Results {#embr201948101-sec-0002}
=======

TEFM is essential for embryonic survival {#embr201948101-sec-0003}
----------------------------------------

To determine the *in vivo* function of TEFM, we generated a conditional knockout allele by flanking exon 2 of *Tefm* with loxP sites (Fig [1](#embr201948101-fig-0001){ref-type="fig"}A). The targeted allele was transmitted through the germline, and heterozygous mice (*Tefm* ^+/loxP‐puro^) were mated to mice expressing flp‐recombinase to excise the puromycin (puro) cassette to obtain mice that were heterozygous for the loxP‐flanked *Tefm* allele (*Tefm* ^+/loxP^). Heterozygous knockout mice (*Tefm* ^+/−^) were obtained by breeding *Tefm* ^+/loxP^ mice to mice ubiquitously expressing cre‐recombinase (+/*β‐actin‐cre*) (Fig [1](#embr201948101-fig-0001){ref-type="fig"}A). Intercrossing of *Tefm* ^+/−^ mice produced no viable homozygous knockout (*Tefm* ^−/−^) mice (analyzed offspring, *n* = 94; *Tefm* ^+/+^, *n* = 34, *Tefm* ^+/−^, *n* = 60 and *Tefm* ^−/−^, *n* = 0), demonstrating that loss of *Tefm* results in embryonic lethality. Next, we performed an intercross of *Tefm* ^+/−^ mice and analyzed staged embryos at embryonic day 8.5 (E8.5; analyzed embryos, *n* = 43). All embryos with the *Tefm* ^−/−^ genotype (*n* = 11) were small and lacked heart structure, while embryos with the *Tefm* ^+/+^ (*n* = 10) or *Tefm* ^+/−^ (*n* = 22) genotype were well developed with normal appearance typical of E8.5 embryos (Fig [1](#embr201948101-fig-0001){ref-type="fig"}B). Thus, loss of TEFM causes severe developmental defects and embryonic lethality at E8.5, consistent with the phenotype of other knockout mice with homozygous disruption of genes critical for mtDNA expression and maintenance [11](#embr201948101-bib-0011){ref-type="ref"}, [44](#embr201948101-bib-0044){ref-type="ref"}, [45](#embr201948101-bib-0045){ref-type="ref"}, [46](#embr201948101-bib-0046){ref-type="ref"}.

![Disruption of *Tefm* in the germline and heart\
Targeting strategy for disruption of the *Tefm* gene. LoxP sites flanking exon 2 of the *Tefm* gene together with puromycin selection marker (PuroR) were inserted into the mouse genome by homologous recombination. The PuroR cassette was excised by mating with flp‐recombinase mice to obtain heterozygous floxed *Tefm* mice (*Tefm* ^+/*loxP*^). Whole‐body and tissue‐specific *Tefm* knockout mice were obtained by crossing *Tefm* ^+/*loxP*^ with different cre‐recombinase mice.Morphology of wild‐type (*Tefm* ^+/+^) and *Tefm* homozygous knockout (*Tefm* ^−/−^) embryos at embryonic day 8.5 (analyzed embryos, *n* = 43). Scale bar, 500 μm.Western blot analyses of the TEFM protein level in heart mitochondrial extracts from 8‐week‐old control (L/L) and tissue‐specific *Tefm* knockout (L/L, cre) mice (*n* = 12 mice for each group). VDAC was used as loading control.Survival curve for control (L/L; *n* = 60) and *Tefm* knockout (L/L, cre; *n* = 22) mice.Heart weight to body weight ratio in 4‐ and 8‐week‐old control (L/L) and tissue‐specific *Tefm* knockout mice (L/L, cre). At 4 weeks: L/L *n* = 22, L/L, cre *n* = 15; 8 weeks: L/L *n* = 41, L/L, cre *n* = 39.Data information: In (E), data are presented as mean ± SEM. \*\*\**P *\< 0.001; Student\'s *t*‐test. 4 weeks *P* = 5.041476e‐009, 8 weeks *P* = 1.096535e‐033.](EMBR-20-e48101-g002){#embr201948101-fig-0001}

Disruption of *Tefm* in heart leads to cardiomyopathy {#embr201948101-sec-0004}
-----------------------------------------------------

Next, we disrupted *Tefm* in heart and skeletal muscle by breeding *Tefm* ^+/*loxP*^ mice with transgenic mice expressing cre‐recombinase from the muscle creatinine kinase promoter (*Ckmm‐cre*). The tissue‐specific *Tefm* knockout mice (*Tefm* ^*loxP*/*loxP*^, +/*Ckmm‐cre*), hereafter denoted *Tefm* knockout mice (L/L, cre), were born at expected Mendelian ratios. The depletion of TEFM in heart was verified at the age of 8 weeks by western blot (Fig [1](#embr201948101-fig-0001){ref-type="fig"}C) and reverse transcriptase quantitative PCR (RT--qPCR) analyses (Fig [EV1](#embr201948101-fig-0001ev){ref-type="fig"}A). The *Tefm* knockout mice had a drastically shortened life span with a maximal longevity of 9 weeks (Fig [1](#embr201948101-fig-0001){ref-type="fig"}D). We also observed a progressively decreased body weight (Fig [EV1](#embr201948101-fig-0001ev){ref-type="fig"}B) and enlargement of the heart (Fig [EV1](#embr201948101-fig-0001ev){ref-type="fig"}C--E) in the tissue‐specific *Tefm* knockout mice, resulting in a significant increase in the heart weight to body weight ratio (Fig [1](#embr201948101-fig-0001){ref-type="fig"}E). TEFM is thus essential for normal heart function.

![Disruption of *Tefm* in the germline and heart\
RT--qPCR analyses of the RNA level of *Tefm* in 8‐week‐old control (L/L) and *Tefm* knockout (L/L, cre) mice (*n* = 10 mice for each group).Body weight of 4‐ and 8‐week‐old control and *Tefm* knockout mice. At 4 weeks: L/L *n* = 22, L/L, cre *n* = 15; 8 weeks: L/L *n* = 41, L/L, cre *n* = 39.Heart weight of 4‐ and 8‐week‐old control and *Tefm* knockout mice. At 4 weeks: L/L *n* = 22, L/L, cre *n* = 15; 8 weeks: L/L *n* = 41, L/L, cre *n* = 39.Representative images of hearts of 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group).Representative images of hematoxylin and eosin staining showing heart structure and morphology in 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group). Scale bar, 100 μm.Data information: In (A--C), data are presented as mean ± SEM. \*\*\**P *\< 0.001; Student\'s *t*‐test. (A) *P* = 3,666241e‐010; (B) 4 weeks *P* = 0.0541737, 8 weeks *P* = 1.126271e‐016; (C) 4 weeks *P* = 1.207998e‐006, 8 weeks *P* = 1.305101e‐026.](EMBR-20-e48101-g003){#embr201948101-fig-0001ev}

Loss of TEFM causes severe mitochondrial dysfunction {#embr201948101-sec-0005}
----------------------------------------------------

Transmission electron microscopy analysis of heart tissue from end‐stage knockout mice showed disrupted mitochondrial alignment and disorganized cristae, consistent with severe respiratory chain dysfunction (Fig [2](#embr201948101-fig-0002){ref-type="fig"}A). Quantification of mitochondrial density revealed a 1.5‐fold increase of relative mitochondrial mass in *Tefm* knockout hearts in comparison with controls (Fig [EV2](#embr201948101-fig-0002ev){ref-type="fig"}A). We also observed an increased ratio of levels of mtDNA relative to nuclear DNA (18S rDNA) as determined by Southern blot (Fig [2](#embr201948101-fig-0002){ref-type="fig"}B) and quantitative PCR (qPCR) (Fig [EV2](#embr201948101-fig-0002ev){ref-type="fig"}B) analyses. Further supporting an activation of mitochondrial biogenesis, we also found an increased ratio of VDAC to histone H3 protein levels as determined by western blots (Fig [2](#embr201948101-fig-0002){ref-type="fig"}B). This increase of mitochondrial biogenesis typically occurs in severely respiratory chain deficient tissues, as exemplified by analysis of tissue‐specific *Lrpprc* knockout and *Mterf4* knockout hearts (Fig [2](#embr201948101-fig-0002){ref-type="fig"}B) [45](#embr201948101-bib-0045){ref-type="ref"}, [47](#embr201948101-bib-0047){ref-type="ref"}. The increase of mitochondrial mass likely represents a compensatory biogenesis response typically seen in human patients and mice with severe mitochondrial dysfunction [48](#embr201948101-bib-0048){ref-type="ref"}, [49](#embr201948101-bib-0049){ref-type="ref"}, [50](#embr201948101-bib-0050){ref-type="ref"}. Next, we measured the activities of the individual complexes in the respiratory chain [51](#embr201948101-bib-0051){ref-type="ref"}. We found a drastic decrease in the activity for complexes I, III, and IV in the *Tefm* knockout mice (Fig [2](#embr201948101-fig-0002){ref-type="fig"}C). A moderate decrease in complex II activity was also observed in the absence of TEFM (Fig [2](#embr201948101-fig-0002){ref-type="fig"}C), similar to what has been observed in other models with severe reduction of mtDNA expression [52](#embr201948101-bib-0052){ref-type="ref"}. Consistently, mitochondrial oxygen consumption assays showed decreased OXPHOS capacity after depletion of TEFM (Fig [EV2](#embr201948101-fig-0002ev){ref-type="fig"}C and D). Additionally, the expression and the assembly of the respiratory chain complexes were negatively affected as determined by western blot analyses (Fig [EV2](#embr201948101-fig-0002ev){ref-type="fig"}E) and blue native polyacrylamide gel electrophoresis (BN‐PAGE), followed by western blotting (Fig [EV2](#embr201948101-fig-0002ev){ref-type="fig"}F). Thus, loss of TEFM profoundly impairs OXPHOS, demonstrating that mtDNA transcription elongation is essential for maintaining mitochondrial function.

![Knockout of *Tefm* in heart causes mitochondrial dysfunction\
Transmission electron micrographs of heart tissue in 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group). Scale bar, 2 μm (upper panel) and 1 μm (lower panel).Southern blot analyses of mtDNA levels in control and *Tefm* knockout hearts at the age of 4 and 8 weeks (upper 2 blots; *n* = 6 mice at each time‐point for each group). 18S rDNA was used as loading control. DNA isolated from tissue‐specific *Lrpprc* and *Mterf4* knockout hearts used as controls. Western blot analyses of VDAC and histone H3 protein levels in control and *Tefm* knockout hearts at the age of 4 and 8 weeks (bottom 2 blots; *n* = 6 mice at each time‐point for each group). VDAC represents mitochondria loading, and histone H3 was used as a loading control for nucleus DNA.Respiratory chain complex activities were measured spectrophotometrically and normalized to citrate synthase activity in heart mitochondria from 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group). The analyzed enzyme activities are NADH coenzyme Q reductase (complex I), NADH cytochrome c reductase (complex I/III), succinate dehydrogenase (complex II), and cytochrome c oxidase (complex IV).Barplot of the significantly changed proteins (Benjamini‐Hochberg adjusted *P* \< 0.05) in *Tefm* knockout mice compared to control mice (*n* = 5 mice for each group), organized by individual OXPHOS complexes. Proteins are organized in alphabetical order based on gene name.Boxplots of the protein intensity (LFQ) of TEFM (top) and POLRMT (bottom). Red dot: mean; blue dots: intensity value for each biological replicate (*n* = 5 mice for each group). Horizontal lines: median; box represents the interquartile range (the first quartile (bottom) and third quartile (top) of the intensity value of 5 replicates). The whiskers represent the maximum and minimum values excluding outliers that represent values extend beyond 1.5 times of the interquartile range.Western blot analyses of POLRMT protein levels in control and *Tefm* knockout heart mitochondria at the age of 8 weeks (*n* = 12 mice for each group). VDAC was used as loading control.Data information: In (C), data are presented as mean ± SEM. \*\*\**P *\< 0.001; Student\'s *t*‐test. CI *P* = 4.27443E‐06, CI/CIII *P* = 2.0553E‐05, CII *P* = 2.76012E‐05, CII/CIII *P* = 2.00732E‐07, CIV *P* = 1.72156E‐06. In (D), data are presented as mean (log~2~ \[L/L, cre/L,L\]) ± 95% confidence interval (CI). In (E), boxplot represents the individual intensity values, the adjusted *P*‐values are calculated by the moderated *t*‐test (limma). adj. *P* = 0.0001334 (top), adj. *P* = 2.69E‐05 (bottom).](EMBR-20-e48101-g004){#embr201948101-fig-0002}

![Depletion of TEFM in heart causes mitochondrial dysfunction\
AQuantification of the relative mitochondrial mass by electron microscopy analysis of the heart of 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group).BQuantitative PCR analyses of the relative mtDNA levels in 4‐ and 8‐week‐old control and *Tefm* knockout mice (*n* = 8 mice at each time‐point for each group).C, DOxygen consumption rates measured using an Oroboros oxygen electrode in heart mitochondria isolated from 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group). Phosphorylating, non‐phosphorylating, and uncoupled respiration under carbonyl cyanide 3‐chlorophenylhydrazone states were measured using pyruvate, glutamate, and malate or succinate and rotenone as substrates.EWestern blot analyses of subunits of OXPHOS at the age of 8 weeks (*n* = 15 mice for each group). Nucleus‐encoded subunits of complex I (NDUFB8), complex II (SDHB), complex III (UQCRC2), complex IV (MTCOX1), and complex V (ATP5A) were analyzed. VDAC was used as loading control.FAnalysis of the assembly of the OXPHOS complexes by BN‐PAGE in heart mitochondria of 8‐week‐old control *Tefm* knockout mice (*n* = 6 mice for each group). OXPHOS complexes were detected by western blot following the BN‐PAGE, including complex I (NDUFV2), complex II (SDHA), complex III (UQCRC1), complex IV (COXIV), and complex V (ATP5A).Data information: In (A--D), data are presented as mean ± SEM. \**P *\< 0.05, \*\**P *\< 0.01, \*\*\**P *\< 0.001; Student\'s *t*‐test. A: *P* = 0.0003; B: 4 weeks: *Nd1*/*18S P* = 0.0135973, *Nd6*/*18S P* = 0.00955924, *Cyb*/*18S P* = 0.0114725, 8 weeks: *Nd1*/*18S P* = 1.449815e‐005, *Nd6*/*18S P* = 6.995544e‐005, *Cyb*/*18S P* = 4.002903e‐006. C: *P* = Complex I Phosphorylating *P*=1.355075e‐008, Non‐phosphorylating *P* = 0.00279867, Uncoupled *P* = 0.000431079; D: Complex II Phosphorylating *P*=1.399847e‐007, Non‐phosphorylating *P* = 4.396380e‐008, Uncoupled *P* = 1.662621e‐006.](EMBR-20-e48101-g005){#embr201948101-fig-0002ev}

Massive changes of the mitochondrial proteome in *Tefm* knockout hearts {#embr201948101-sec-0006}
-----------------------------------------------------------------------

To better understand how *Tefm* disruption affects mitochondrial function, purified mitochondria from hearts were subjected to label‐free quantitative proteomics. We identified a total of 813 proteins classified as mitochondrial according to MitoCarta 2.0 [53](#embr201948101-bib-0053){ref-type="ref"}. Of these, 62.5% (508/813) were significantly changed and showed either increased (338/508) or decreased (170/508) protein levels in mitochondria lacking TEFM. Manual classification of the differentially expressed proteins revealed that several mitochondrial processes, including oxidative phosphorylation, fatty acid and amino acid metabolic pathways, protein translation (ribosome assembly), mitochondrial structure/morphology, apoptosis, and RNA metabolism, were massively affected by depletion of TEFM (Fig [EV3](#embr201948101-fig-0003ev){ref-type="fig"}A--C). A closer inspection of the mitochondrial proteome showed a significant decrease of the subunits of OXPHOS complexes I, III, IV, and V (Fig [2](#embr201948101-fig-0002){ref-type="fig"}D) and increase of respiratory chain complex assembly factors (Fig [EV3](#embr201948101-fig-0003ev){ref-type="fig"}B). As expected, TEFM protein levels were significantly decreased (Fig [2](#embr201948101-fig-0002){ref-type="fig"}E). Interestingly, protein levels of nearly all of the small ribosomal subunits (28S) were increased while the majority of the large ribosomal (39S) subunits were decreased (Fig [EV3](#embr201948101-fig-0003ev){ref-type="fig"}C). These data show that loss of TEFM alters mitochondrial ribosome composition, which may impair mitochondrial protein translation. Furthermore, we observed a remarkable increase of POLRMT protein levels in TEFM‐depleted mitochondria (Fig [2](#embr201948101-fig-0002){ref-type="fig"}E and F), consistent with our previous results showing that knockout of a variety of genes needed for mtDNA expression leads to increased POLRMT levels [54](#embr201948101-bib-0054){ref-type="ref"}.

![Proteome of *Tefm* knockout heart mitochondria\
Beeswarm plot presenting the distribution of differentially expressed proteins (Benjamini--Hochberg adj. *P *\< 0.05) in mitochondrial pathways after knockout of *Tefm* at 8 weeks of age (*n* = 5 mice for each group).Heatmap showing differentially expressed respiratory chain complexes assembly factors (upper panel) and RNA metabolism‐related proteins (lower panel) in *Tefm* knockout mice in comparison to controls \[L/L, cre/L/L\].Volcano scatterplots depicting the expression levels of the subunits of the small (28S) and large (39S) ribosomes in green and blue, respectively. Red dotted line, Benjamini--Hochberg adj. *P* = 0.05.](EMBR-20-e48101-g007){#embr201948101-fig-0003ev}

*Tefm* and *Polrmt* double‐heterozygous deletion does not affect mitochondrial function or mtDNA transcription {#embr201948101-sec-0007}
--------------------------------------------------------------------------------------------------------------

We proceeded to investigate how a moderate reduction of TEFM and/or POLRMT levels affects mitochondrial function and mtDNA transcription. *Tefm* ^+/−^ mice were crossed with *Polrmt* heterozygous knockout (*Polrmt* ^+/−^) mice [11](#embr201948101-bib-0011){ref-type="ref"} to generate double‐heterozygous knockout mice (*Tefm* ^+/−^, *Polrmt* ^+/−^). Western blot analyses showed decreased protein levels of TEFM and POLRMT in double‐heterozygous knockouts, in accordance with the 50% reduction in *Tefm* and *Polrmt* gene dosage (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}A). The whole‐body reduction of TEFM and POLRMT levels did not lead to any obvious phenotype, and all mice were viable and healthy at the age of 52 weeks. The mtDNA levels were assessed by qPCR at 16 weeks of age and showed no difference between double‐heterozygous knockout and control mice (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}B). Additionally, western blot analyses showed normal levels of the OXPHOS subunits in heart mitochondria from double‐heterozygous mice (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}C), showing that OXPHOS is not affected by a combined moderate decrease of TEFM and POLRMT levels. Furthermore, northern blot analyses of the steady‐state levels of individual mtRNA transcripts, including mt‐rRNAs, mt‐mRNAs (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}D and [Appendix Fig S1A](#embr201948101-sup-0001){ref-type="supplementary-material"}), and mt‐tRNAs (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}E and [Appendix Fig S1B and C](#embr201948101-sup-0001){ref-type="supplementary-material"}), showed no change in double‐heterozygous mice in comparison with controls. These data show that a mild reduction in TEFM and POLRMT protein levels does not affect mtDNA expression.

![Characterization of whole‐body *Tefm* and *Polrmt* double‐heterozygous knockout mice and the effects of TEFM depletion on mitochondrial transcripts and the mtDNA replication machinery\
Western blot analyses of POLRMT and TEFM protein levels in heart mitochondrial extracts from 16‐week‐old *Tefm* and *Polrmt* double‐heterozygous knockout mice (*n* = 6 mice for each group). VDAC was used as loading control.Quantitative PCR analyses of the relative mtDNA levels in 16‐week‐old *Tefm* and *Polrmt* double‐heterozygous knockout mice (*n* = 6 mice for each group). *18S* was used to normalize for nuclear input.Western blot analyses of subunits from individual OXPHOS complexes at the age of 16 weeks (*n* = 6 mice for each group). Nucleus‐encoded subunits of complex I (NDUFB8), complex II (SDHB), complex III (UQCRC2), complex IV (MTCOX1), and complex V (ATP5A) were analyzed. VDAC was used as loading control.Northern blot analyses of mitochondrial transcripts of mt‐rRNAs and mt‐mRNAs in 16‐week‐old *Tefm* and *Polrmt* double‐heterozygous knockout mouse hearts (*n* = 8 mice for each group). *18S rRNA* was used as loading control.Northern blot analyses of mitochondrial mt‐tRNA transcripts in 16‐week‐old *Tefm* and *Polrmt* double‐heterozygous knockout mouse hearts (*n* = 8 mice for each group). *5.8S rRNA* was used as loading control.RT--qPCR analyses of the mitochondrial transcripts in 8‐week‐old control and *Tefm* knockout mice (*n* = 12 mice for each group).Western blot analyses of TFAM and TFB2M in the 8‐week‐old control and *Tefm* knockout mice (*n* = 12 mice for each group). SDHA was used as loading control.Western blot analyses of the subunit A of the DNA polymerase γ (POLγA), DNA helicase TWINKLE, and ssDNA‐binding protein (SSBP1) in 8‐week‐old control and *Tefm* knockout mice (*n* = 12 mice for each group). VDAC was used as loading control.Data information: In (B), data are presented as mean ± SEM. Statistical analysis was performed using one‐way analysis of variance (ANOVA). There is no difference between groups. In (F), data are presented as mean ± SEM. \*\*\**P *\< 0.001; Student\'s *t*‐test. (F) HSP transcripts: *12S rRNA P* = 0.000728399; *16S rRNA P* = 1.10763E‐06; *Nd1 P* = 2.63285E‐06; *Nd2 P* = 0.00152084; *Cox1 P* = 1.29269E‐06; *Cox2 P* = 1.9267E‐05; *Atp8 P* = 3.05955E‐07; *Atp6 P* = 0.000849436; *Cox3 P* = 4.98506E‐05; *Nd3 P* = 4.07442E‐05; *Nd4 P* = 1.43029E‐06; *Nd5 P* = 6.04136E‐05; *Cyb P* = 0.00882284; LSP transcript: *Nd6 P* = 0.00139773.](EMBR-20-e48101-g009){#embr201948101-fig-0004ev}

Loss of TEFM impairs mtDNA transcription elongation and drastically decreases steady‐state levels of promotor‐distal transcripts {#embr201948101-sec-0008}
--------------------------------------------------------------------------------------------------------------------------------

Since TEFM has previously been identified as a component of the mitochondrial transcription machinery *in vitro* [16](#embr201948101-bib-0016){ref-type="ref"}, [17](#embr201948101-bib-0017){ref-type="ref"}, [19](#embr201948101-bib-0019){ref-type="ref"}, we proceeded to analyze mtRNA transcript levels in hearts from 4‐ and 8‐week‐old *Tefm* knockout mice. Northern blot analyses showed a drastic reduction in the steady‐state levels of promoter‐distal transcripts (mt‐rRNAs, mt‐mRNAs, and mt‐tRNAs) encoded on both strands in the absence of TEFM (Fig [3](#embr201948101-fig-0003){ref-type="fig"}A--E). In contrast, the levels of promoter‐proximal transcripts were either increased, such as mt‐tRNA^F^ and mt‐tRNA^P^, or remained near normal, such as *12S rRNA*, mt‐tRNA^V^, and mt‐tRNA^E^ (Fig [3](#embr201948101-fig-0003){ref-type="fig"}A--E). The alterations in levels of mt‐rRNAs and mt‐mRNAs were independently confirmed by RT--qPCR analyses (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}F). Moreover, the near normal *12S rRNA* levels and decreased *16S rRNA* levels explain the alteration of steady‐state levels of mitoribosomal proteins found in the mitoproteomics data set (Fig [EV3](#embr201948101-fig-0003ev){ref-type="fig"}C) and are also consistent with a previous report showing that normal levels of the *12S rRNA* and low levels of *16S rRNA* decrease the levels of large ribosomal subunit proteins, whereas the levels of the small ribosomal subunit proteins remain unaffected [34](#embr201948101-bib-0034){ref-type="ref"}. Furthermore, we investigated *de novo* mtRNA synthesis by *in organello* labeling with ^32^P‐labeled uridine triphosphate (^32^P‐UTP) and observed that loss of TEFM led to a dramatically reduced mtRNA levels, predominantly affecting the production of longer transcripts (Fig [4](#embr201948101-fig-0004){ref-type="fig"}A). Therefore, loss of TEFM impairs mtDNA transcription, particularly transcription elongation, resulting in a severe reduction of promoter‐distal transcripts from both strands. The defect in transcription elongation is accompanied by an increase of transcription initiation events, which may also be supported by the increased levels of TFAM and TFB2M (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}G) and POLRMT (Fig [2](#embr201948101-fig-0002){ref-type="fig"}E and F), thus leading to drastically increased levels of promoter‐proximal transcripts.

![Loss of TEFM impairs mtDNA transcription elongation and decreases steady‐state levels of promotor‐distal transcripts\
ASchematic linear map of mouse mtDNA indicating the relative position of mtRNA transcripts analyzed by northern blot.B--ENorthern blot analyses (B and D) and relative quantification (C and E) of mtRNA transcripts in control and *Tefm* knockout mouse hearts at the age of 4 and 8 weeks (*n* = 12 mice at each time‐point for each group). *18S rRNA* and *5.8S rRNA* were used as loading controls, respectively.Data information: In (C and E), data are presented as mean ± SEM. \**P *\< 0.05, \*\**P *\< 0.01, and \*\*\**P *\< 0.001; Student\'s *t*‐test. (C) HSP transcripts: *12S rRNA* 4 weeks *P* = 0.005966044, 8 weeks *P* = 0.0806819; *16S rRNA* 4 weeks *P* = 0.000223004, 8 weeks *P* = 0.00243443; *Nd1* 4 weeks *P* = 0.0352088, 8 weeks *P* = 0.000344158; *Cox1* 4 weeks *P* = 0.000353895, 8 weeks *P* = 0.00145773; *Cox2* 4 weeks *P* = 0.0145193, 8 weeks *P* = 0.00578484; *Cox3* 4 weeks *P* = 0.00834317, 8 weeks *P* = 0.000392364; *Nd5*/*Cyb* 4 weeks *P* = 0.0010185, 8 weeks *P* = 0.00153049; *Nd5* 4 weeks *P* = 0.024621, 8 weeks *P* = 7.38074E‐05; *Cyb* 4 weeks *P* = 3.46175E‐06, 8 weeks *P* = 0.000991942; LSP transcript: *Nd6* 4 weeks *P* = 0.000162704, 8 weeks *P* = 0.000187855. (E) HSP transcripts: *Tf* 4 weeks *P* = 0.0297685, 8 weeks *P* = 0. 000212544; *Tv* 4 weeks *P* = 0.842023, 8 weeks *P* = 0.269231; *Tl1* 4 weeks *P* = 0.00921072, 8 weeks *P* = 0.000430068; *Tm* 4 weeks *P* = 0.0084742, 8 weeks *P* = 0.000142524; *Tk* 4 weeks *P* = 0.00297015, 8 weeks *P* = 0.00010425; *Ts2* 4 weeks *P* = 0.0128829, 8 weeks *P* = 2.27321E‐05; *Tl2* 4 weeks *P* = 0.00701324, 8 weeks *P* = 0.000411549; *Tt* 4 weeks *P* = 0.00572118, 8 weeks *P* = 0.000807943; LSP transcript: *Tp* 4 weeks *P* = 0.0427191, 8 weeks *P* = 0.0483328; *Te* 4 weeks *P* = 0.464031, 8 weeks *P* = 0.13412; *Ts1* 4 weeks *P* = 0.0382215, 8 weeks *P* = 0.000478237; *Tc* 4 weeks *P* = 0.00418795, 8 weeks *P* = 0.000287525; *Tn* 4 weeks *P* = 0.00531668, 8 weeks *P* = 0.000374367; *Ta* 4 weeks *P* = 0.00247257, 8 weeks *P* = 0.000564597; *Tq* 4 weeks *P* = 0.00385524, 8 weeks *P* = 0.000727981.](EMBR-20-e48101-g006){#embr201948101-fig-0003}

![Accumulated shorter LSP transcripts in TEFM‐depleted mitochondria do not contribute to mtDNA replication\
*In organello* transcription analyses using heart mitochondria isolated from 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group). The steady‐state levels of *12S rRNA* and mt‐tRNA^V^ were used as endogenous controls, due to their unchanged levels. VDAC was used as loading control for the equal input of mitochondrial extracts. This experiment has performed five times with either two or three replicates.Northern blot analyses of *7S RNA* level in 4‐ and 8‐week‐old control and *Tefm* knockout mouse hearts (*n* = 12 mice at each time‐point for each group). *18S rRNA* was used as loading control. RNA from tissue‐specific *Mterf4* knockout mouse hearts and tissue‐specific *Polrmt* knockout mouse hearts was loaded as positive and negative control, respectively.Southern blot analyses of mtDNA to obtain 7S DNA in 8‐week‐old control and *Tefm* knockout mice. Heart mitochondria from three control or knockout mice were pooled for preparation of mtDNA. Equal amounts of mtDNA shown on the top of the gel were loaded as the endogenous control. This experiment has performed three times.*In organello* replication assays were performed on heart mitochondria isolated from 8‐week‐old control and *Tefm* knockout mice (*n* = 5 mice for each group). VDAC was used as loading control.Northern blot analyses of the *7S RNA* levels in 4‐ and 8‐week‐old control and *Tefm* knockout mouse hearts (*n* = 12 mice for each group). *5S rRNA* was used as loading control. RNA from tissue‐specific *Mterf4* knockout mouse hearts and tissue‐specific *Polrmt* knockout mouse hearts was loaded as positive and negative control, respectively.Mapping 3′ termini of mitochondrial *7S RNA*/early LSP transcripts in control (L/L) and *Tefm* knockout (L/L, cre) mouse hearts at the age of 8 weeks. A 3′ RACE was performed using linker‐ligated RNA and a forward primer corresponding to the first 45 bp from the transcription initiation site at LSP. CSB, conserved sequence block.](EMBR-20-e48101-g008){#embr201948101-fig-0004}

Accumulation of short LSP transcripts in TEFM‐deficient mitochondria does not contribute to mtDNA replication {#embr201948101-sec-0009}
-------------------------------------------------------------------------------------------------------------

Transcripts initiated from LSP frequently terminate at the conserved sequence blocks (CSBs) resulting in the formation of *7S RNA*, which is the most promoter‐proximal L strand transcript [5](#embr201948101-bib-0005){ref-type="ref"}. To measure *7S RNA* levels in *Tefm* knockout mice, a ^32^P‐radiolabeled RNA probe, corresponding to the first 45 base pairs (bp) of the RNA produced by transcription initiation at LSP, was used for northern blot analyses (Fig [4](#embr201948101-fig-0004){ref-type="fig"}B). Samples from tissue‐specific *Mterf4* knockouts, which are known to have increased *7S RNA* levels, and tissue‐specific *Polrmt* knockouts, which are known to lack *7S RNA* [11](#embr201948101-bib-0011){ref-type="ref"}, [47](#embr201948101-bib-0047){ref-type="ref"}, were included as positive and negative controls, respectively. The levels of *7S RNA* were markedly increased in *Tefm* knockout mice in comparison with controls (Fig [4](#embr201948101-fig-0004){ref-type="fig"}B). The drastically increased abundance of *7S RNA* prompted us to evaluate mtDNA replication, because LSP transcripts are used to prime initiation of mtDNA replication in the CSB region [7](#embr201948101-bib-0007){ref-type="ref"}, [21](#embr201948101-bib-0021){ref-type="ref"}, [55](#embr201948101-bib-0055){ref-type="ref"}. Surprisingly, when loaded with equal amounts of mtDNA, the steady‐state levels of 7S DNA within the D‐loop were markedly reduced in *Tefm* knockout heart mitochondria (Fig [4](#embr201948101-fig-0004){ref-type="fig"}C). Furthermore, analysis of *de novo* mtDNA synthesis revealed a drastic reduction in the synthesis of 7S DNA and full‐length mtDNA in the absence of TEFM (Fig [4](#embr201948101-fig-0004){ref-type="fig"}D). These results show that loss of TEFM impairs mtDNA replication. To address the question why the high levels of *7S RNA* are not associated with increased mtDNA replication, we performed further analysis of the promoter‐proximal transcripts using high‐resolution polyacrylamide gels (Fig [4](#embr201948101-fig-0004){ref-type="fig"}E). A range of prematurely terminated RNA species shorter than full‐length *7S RNA* were observed in the *Tefm* knockout mice (Fig [4](#embr201948101-fig-0004){ref-type="fig"}E). The tissue‐specific *Mterf4* knockout mice also contain high levels of *7S RNA* reflecting the increase in the rate of transcription in these mice, but in this case the size distribution of *7S RNA* transcripts is the same as in controls without evidence for premature termination. Further analysis with the rapid amplification 3′ cDNA ends method (3′RACE) confirmed the findings from the northern blots and showed premature termination of *7S RNAs* (Fig [4](#embr201948101-fig-0004){ref-type="fig"}F and [Table EV1](#embr201948101-sup-0003){ref-type="supplementary-material"}). Promoter‐proximal transcription termination for RNA primer formation has been attributed to the G‐quadruplex structure of CSBII [22](#embr201948101-bib-0022){ref-type="ref"}, and it has been reported that TEFM is necessary for reading through this sequence [27](#embr201948101-bib-0027){ref-type="ref"}. However, loss of TEFM does not generate a distinct termination product at CSBII, but rather a range of short, prematurely terminated transcripts (Fig [4](#embr201948101-fig-0004){ref-type="fig"}E and F).

We also investigated the expression of core factors involved in mtDNA replication, including the subunit A of the DNA polymerase γ (POLγA), the DNA helicase TWINKLE, and the ssDNA‐binding protein (SSBP1) by western blot analyses. We found that POLγA and TWINKLE were significantly increased at the protein level, while SSBP1 expression remained unchanged in TEFM‐depleted mitochondria (Fig [EV4](#embr201948101-fig-0004ev){ref-type="fig"}H). Thus, the defective mtDNA replication capacity does not result from a lack of replication‐related proteins. Therefore, our results show that the absence of TEFM causes accumulation of very short, promoter‐proximal transcripts initiated from LSP, which prevent proper RNA primer formation to promote mtDNA replication.

Transcriptome‐wide analysis of RNA from *Tefm* knockout hearts suggests a link between transcription elongation and RNA processing {#embr201948101-sec-0010}
----------------------------------------------------------------------------------------------------------------------------------

We further analyzed the mitochondrial transcriptome in total heart tissue and purified mitochondria from *Tefm* knockout and control mice by RNA sequencing (RNA‐Seq). We performed TruSeq RNA‐Seq, to capture long transcripts, such as mt‐mRNAs and mt‐rRNAs (Fig [5](#embr201948101-fig-0005){ref-type="fig"}A and [Appendix Fig S2A](#embr201948101-sup-0001){ref-type="supplementary-material"}), and small RNA sequencing to selectively capture mt‐tRNAs and the *7S RNA* ([Appendix Fig S2B and C](#embr201948101-sup-0001){ref-type="supplementary-material"} and Fig [EV5](#embr201948101-fig-0005ev){ref-type="fig"}A). Analyses of both RNA‐Seq datasets showed a drastic increase in reads corresponding to promoter‐proximal transcripts from both LSP and HSP (e.g., mt‐tRNA^F^ and mt‐tRNA^P^), whereas reads corresponding to promoter‐distal transcripts from both strands (*16S rRNA*, all mt‐mRNAs and most mt‐tRNAs) were decreased (Fig [5](#embr201948101-fig-0005){ref-type="fig"}A and [Appendix Fig S2](#embr201948101-sup-0001){ref-type="supplementary-material"}). These data are consistent with the results from our northern blot and RT--qPCR analyses (Figs [3](#embr201948101-fig-0003){ref-type="fig"} and [EV4](#embr201948101-fig-0004ev){ref-type="fig"}F). The small RNA‐Seq dataset revealed the presence of shorter, prematurely terminated transcripts in *Tefm* knockout heart mitochondria (Fig [EV5](#embr201948101-fig-0005ev){ref-type="fig"}A), which provides independent confirmation of the results shown in Fig [4](#embr201948101-fig-0004){ref-type="fig"}E and F.

![Transcriptome‐wide analysis reveals that mtDNA transcription elongation is linked to RNA processing\
Transcriptome‐wide analysis of the effects of TEFM loss on mtRNA transcripts by TruSeq RNA sequencing. A complete map of mtDNA showing the change in sequence read coverage (log~2~ fold change \[L/L, cre/L/L\]) between *Tefm* knockout (L/L, cre; *n* = 4) and control (L/L; *n* = 3) mice on both strands. Increased reads are shown in red and decreased reads in blue. The mtDNA is displayed in the central track, with mt‐rRNAs in green, mt‐mRNAs in light blue and mt‐tRNAs in gray.Strand‐specific RT--qPCR detection of the mitochondrial precursor transcripts containing the antisense of mt‐tRNA^A^ and antisense of mt‐tRNA^C^ in control and *Tefm* knockout mice (*n* = 12 mice for each group). The mt‐mRNAs are shown in light blue and mt‐tRNAs in gray. Arrows show the binding position of qPCR primers. Actin transcript was used as endogenous control.Strand‐specific RT--qPCR detection of the mitochondrial precursor transcripts spanning the junction of *Nd5* and antisense of *Nd6* in control and *Tefm* knockout mice (*n* = 25 mice for each group). The mt‐mRNAs are shown in light blue. Arrows show the binding position of qPCR primers. Actin transcript was used as endogenous control.Northern blot analyses of the precursor transcripts containing the antisense of mt‐tRNA^A^ in 4‐ and 8‐week‐old control and *Tefm* knockout mouse hearts (*n* = 6 mice for each group).Data information: In (B and C), data are presented as mean ± SEM. \**P *\< 0.05, \*\**P *\< 0.01; Student\'s *t*‐test. C: *P* = 0.0089; D: *P* = 0.0260.](EMBR-20-e48101-g010){#embr201948101-fig-0005}

![Transcriptome‐wide analysis of *Tefm* knockout hearts and TEFM interacts with mtRNA processing factors\
Normalized read counts corresponding to the light‐promoter region from small RNA sequencing of mitochondrial transcripts showing the *7S RNA* read counts (L/L, *n* = 4; L/L, cre *n* = 3).Western blot analyses of RNA processing‐related proteins in isolated mitochondria (input) and eluates when TEFM‐BirA\* was used as a bait. Eluate (100%), input (1%).](EMBR-20-e48101-g011){#embr201948101-fig-0005ev}

The TruSeq technique only captures mt‐tRNAs (or other short RNAs) if they are part of longer, unprocessed transcripts and does not detect free mt‐tRNAs [34](#embr201948101-bib-0034){ref-type="ref"}. This analysis revealed a marked increase of mt‐tRNA reads in the *Tefm* knockout datasets, indicating an accumulation of RNA processing intermediates (Fig [5](#embr201948101-fig-0005){ref-type="fig"}A). We found that the enrichment of unprocessed transcripts was particularly prominent in regions containing mt‐tRNA clusters or regions spanning tRNA‐mRNA junctions (Fig [5](#embr201948101-fig-0005){ref-type="fig"}A). To further confirm the increase of unprocessed transcripts in *Tefm* knockout mice, we performed strand‐specific RT--qPCR (Fig [5](#embr201948101-fig-0005){ref-type="fig"}B and C). H‐strand cDNAs were generated using the anti‐mt‐tRNA^C^‐R primer, which is complementary to the antisense strand relative to mt‐tRNA^C^, and the anti‐*Nd6*‐R primer, which is complementary to the antisense strand of *Nd6*. Synthesis of cDNA with these primers thus generates ssDNA that corresponds to RNAs that are antisense to mt‐tRNA^C^ and *Nd6*, respectively. In the next step, pairs of primers were used to amplify the cDNA to get dsDNA for analysis by qPCR. As shown in Fig [5](#embr201948101-fig-0005){ref-type="fig"}B and C, these unprocessed transcripts were upregulated in the absence of TEFM. Moreover, northern blot analyses with a probe corresponding to antisense mt‐tRNA^A^ confirmed the presence of long unprocessed transcripts in TEFM knockout mice identified by TruSeq (Fig [5](#embr201948101-fig-0005){ref-type="fig"}D). We thus conclude that absence of TEFM leads to impaired RNA processing.

TEFM interacts with RNA processing factors {#embr201948101-sec-0011}
------------------------------------------

To further investigate the role of TEFM in RNA processing, we searched for TEFM interacting partners using a proximity‐labeling (BioID) assay [56](#embr201948101-bib-0056){ref-type="ref"} followed by affinity purification and mass spectrometry of biotinylated proteins. Using Flp‐In T‐REx 293 cells, we generated a stable cell line that constitutively expressed human TEFM as a fusion protein containing a carboxyterminal BirA\*‐HA tag (TEFM‐BirA\*). As expected, our results confirmed that TEFM interacts with POLRMT (Fig [6](#embr201948101-fig-0006){ref-type="fig"}), as previously reported [16](#embr201948101-bib-0016){ref-type="ref"}, [17](#embr201948101-bib-0017){ref-type="ref"}, [19](#embr201948101-bib-0019){ref-type="ref"}. In addition, we identified a number of RNA processing‐related proteins that interacted with TEFM, including the RNase P complex (MRPP1‐3), GRSF1, FASTKD5, ELAC2, mtPAP, and the components of mitochondrial RNA degradosome (SUPV3L1‐PNPase) complex (Fig [6](#embr201948101-fig-0006){ref-type="fig"}), which are all reported to be localized in or adjacent to RNA granules [29](#embr201948101-bib-0029){ref-type="ref"}, [30](#embr201948101-bib-0030){ref-type="ref"}, [37](#embr201948101-bib-0037){ref-type="ref"}, [40](#embr201948101-bib-0040){ref-type="ref"}, [41](#embr201948101-bib-0041){ref-type="ref"}, [57](#embr201948101-bib-0057){ref-type="ref"}. Western blot analyses of the eluates confirmed the association between RNA processing factors (ELAC2, GRSF1, and MRPP1) and TEFM (Fig [EV5](#embr201948101-fig-0005ev){ref-type="fig"}B). As expected, naturally biotinylated proteins, such as carboxylases, were also identified. Furthermore, some very abundant mitochondrial proteins, including respiratory chain subunits, ribosomal proteins, and proteases, were also identified and likely represent the commonly found contaminants, as previously reported in a similar study [58](#embr201948101-bib-0058){ref-type="ref"}.

![TEFM interacts with RNA processing factors\
Volcano plot showing TEFM‐BioID. TEFM‐BirA\*‐HA was stably expressed in HEK 293 cells, followed by streptavidin affinity purification and mass spectrometry analysis to detect the associated proteins. Mitochondrial targeted BirA\* (MTS‐BirA\*) was used as a control. The significantly enriched proteins are presented above the horizontal dashed line with 5% false discovery rate (FDR) significance. The blue dots highlight proteins involved in mtDNA transcription, and the green dots represent proteins involved in RNA metabolism. All other proteins are in gray.](EMBR-20-e48101-g012){#embr201948101-fig-0006}

Discussion {#embr201948101-sec-0012}
==========

We report here that TEFM acts as a general elongation factor for mtDNA transcription in mammalian mitochondria. Without TEFM, the vast majority of transcripts initiated at LSP does not reach very far and is mostly terminated near CSBIII after initiation. We also report that some regions of mtDNA, such as those with clusters of mt‐tRNA genes, seem to be particularly difficult sequences to bypass in the absence of TEFM, likely because of strong secondary structures. Recent computational analyses of the human mtDNA sequence suggest that there are ∼200 putative G‐quadruplex forming sequences [59](#embr201948101-bib-0059){ref-type="ref"}, [60](#embr201948101-bib-0060){ref-type="ref"}, whose presence has been confirmed in live cells [61](#embr201948101-bib-0061){ref-type="ref"}. The existence of G‐quadruplexes in the non‐transcribed DNA strand constitutes a very strong transcription barrier for a progressing RNA polymerase [62](#embr201948101-bib-0062){ref-type="ref"}, and a G‐quadruplex in nascent RNA strongly stimulates transcription termination at CSBII [22](#embr201948101-bib-0022){ref-type="ref"}, [23](#embr201948101-bib-0023){ref-type="ref"}. It should be noted that the region just upstream of CSBIII is predicted to have the potential to form G‐quadruplex by the QGRS mapper, although it has only a modest effect on transcription termination *in vitro* [22](#embr201948101-bib-0022){ref-type="ref"}. Clearly, transcription in the absence of TEFM *in vivo* leads to an accumulation of very short transcripts that terminate prematurely and fail to pass through the predicted G‐quadruplex at CSBIII.

Unexpectedly, the *in vivo* data we present here also show that loss of TEFM affects RNA processing. By using several independent methods, i.e., RNA‐Seq, northern blots, and RT--qPCR, we found abundant, unprocessed transcripts in the absence of TEFM, particularly in regions with strong secondary structures, such as mt‐tRNA gene clusters. Label‐free quantitative proteomics showed increased levels of many proteins involved in RNA processing in the absence of TEFM. By performing BioID assays, we found interactions between TEFM and a range of proteins indispensable for endonucleolytic processing of mtRNAs, e.g., the RNase P complex, ELAC2, and GRSF1. Our results thus suggest that TEFM may interact with the RNA processing machinery in mammalian mitochondria, although further studies are needed to reveal possible molecular mechanisms. A possible coupling between transcription elongation and RNA processing could increase the accuracy and efficiency of pre‐RNA maturation and may also provide new regulatory opportunities to control mtDNA gene expression. It should be pointed out that transcription and pre‐mRNA processing are coupled processes also in the nucleus, with important consequences for transcript maturation and gene regulation. In the nucleus, the carboxyl‐terminal domain (CTD) of the largest RNA polymerase II subunit is phosphorylated during transcription initiation and this leads to recruitment of proteins involved in RNA processing, including factors required for 5′‐capping, splicing, and polyadenylation. By acting as a landing pad that brings processing factors in close proximity to the actively transcribing RNA polymerase II, the nascent pre‐mRNA can be efficiently processed during active transcription elongation. For instance, the nascent pre‐mRNA is capped (attachment of 7‐methylguanosine by a 5′‐5′ triphosphate linkage) already after transcription of the first 20--30 nucleotides, just as the 5′ end of the nascent transcript emerges from the RNA exit channel [63](#embr201948101-bib-0063){ref-type="ref"}. Co‐transcriptional processing also helps to explain how chromatin modification, such as histone methylation (H3K36), can mark expressed exons [64](#embr201948101-bib-0064){ref-type="ref"}. Future work is needed to reveal additional factors required for co‐transcriptional processing in mitochondria and to define their regulatory potential.

Based on results from *in vitro* transcription experiments, previous work suggested that TEFM regulates the formation of the RNA primers needed for initiation of mtDNA replication [27](#embr201948101-bib-0027){ref-type="ref"}. This study led to the postulation of a model whereby regulation of TEFM controls a switch between mtDNA gene expression and replication. On the one hand, high levels of TEFM will allow transcription to proceed past CSBII to promote near genome‐length transcription for expression of mtDNA‐encoded genes. On the other hand, low levels of TEFM will lead to transcription arrest at CSBII and formation of RNA primers needed for mtDNA replication. Data presented here and elsewhere suggest that the mechanisms of primer formation are more complicated than described in the replication--transcription switch model. First, as we show here, loss of TEFM does not lead to an upregulation of mtDNA replication initiation as predicted by the model. Instead, low levels of TEFM cause a drastic decrease in *de novo* mtDNA replication and a depletion of nascent D‐loop strands (7S DNA). Second, transcripts formed by premature termination at CSBII cannot be directly used as primers for initiation of mtDNA replication, but must first be processed to shorter transcripts by RNase HI [65](#embr201948101-bib-0065){ref-type="ref"}. A role for RNase H in primer maturation has also been reported in other systems. For instance, RNase H is required for R‐loop processing and replication primer formation during ColE1 plasmid replication in bacteria [66](#embr201948101-bib-0066){ref-type="ref"}.

Another interesting finding is that loss of TEFM leads to a dramatic increase of POLRMT levels (Fig [2](#embr201948101-fig-0002){ref-type="fig"}E and F) and a mild increase of MRPL12 levels (Fig [EV3](#embr201948101-fig-0003ev){ref-type="fig"}C). One may argue that MRPL12 binds to and stabilizes POLRMT [67](#embr201948101-bib-0067){ref-type="ref"}, [68](#embr201948101-bib-0068){ref-type="ref"}, but we have failed to confirm this proposed interaction in previous studies [11](#embr201948101-bib-0011){ref-type="ref"}, [54](#embr201948101-bib-0054){ref-type="ref"}. In density gradients with wild‐type mitochondrial extracts, POLRMT is found in fractions containing mtDNA, whereas MRPL12 is present in mtDNA‐free fractions containing other ribosomal proteins [11](#embr201948101-bib-0011){ref-type="ref"}, arguing against a significant interaction between MRPL12 and POLRMT. Recently, we analyzed the proteome of 5 tissue‐specific knockout mouse mutants with disruption of mtDNA gene expression at different levels and found that the expression of *12S* and *16S rRNA* was critical for the stability of most mitoribosomal proteins [54](#embr201948101-bib-0054){ref-type="ref"}. In all of the 5 knockouts, the POLRMT levels were substantially increased (except in the *Polrmt* knockout mice), but the overall levels of mitoribosomal proteins followed the levels of *12S* and *16S rRNA*. It should be noted that MRPL12 levels were near normal in the absence of *12S* and *16S rRNA*, but were increased in the two knockouts that can form mitochondrial ribosomes (Fig [5](#embr201948101-fig-0005){ref-type="fig"} in [54](#embr201948101-bib-0054){ref-type="ref"}). MRPL12 thus belongs to a small subset of mitoribosomal proteins that remains stable in the absence of *12S* and *16S rRNA*, and the POLRMT protein levels are upregulated independent of changes in MRPL12 levels.

In summary, the *in vivo* results we report here establish TEFM as a crucial component of the mitochondrial transcription machinery. In the absence of TEFM, transcription elongation is severely impaired, resulting in reduced mtDNA expression and a bioenergetics crisis. In contrast to a recently presented model, we find that reduced levels of TEFM do not increase the formation of RNA primers needed for DNA replication. Instead, we show that TEFM is necessary both for replication primer formation and for near genome‐length transcription for mtDNA expression. Our *in vivo* results are thus inconsistent with a model where TEFM acts as a switch that regulates the balance between replication and gene expression of mtDNA, and instead, we report a possible connection between transcription elongation to RNA processing that needs to be explained in future molecular studies.

Materials and Methods {#embr201948101-sec-0013}
=====================

Experimental model and subject details {#embr201948101-sec-0014}
--------------------------------------

### Mouse models {#embr201948101-sec-0015}

Generation of conditional *Tefm*‐knockout mice. The targeting vector for disruption of *Tefm* in embryonic stem cells (derived from C57BL/6N) was generated by Taconic Artemis using BAC clones from the C57BL/6J RPCIB‐731 BAC library. To generate the conditional *Tefm*‐knockout allele, exon 2 of the *Tefm* locus was flanked by loxP sites and a puromycin resistance cassette (PuroR) flanked by Frt sites was introduced in intron 1 as a positive selection marker. The PuroR was removed by the mating of *Tefm* ^+/*loxP*‐Puro^ mice with transgenic mice with ubiquitously expressing flp‐recombinase. The resulting *Tefm* ^+/*loxP*^ mice were subsequently crossed with mice ubiquitously expressing cre‐recombinase under the control of (i) the *β‐actin* promoter (+/*β‐actin*) to generate heterozygous *Tefm* knockout mice (*Tefm* ^+/*−*^) or (ii) the muscle creatinine kinase promoter (+/*Ckmm‐cre*) to generate heart and skeletal muscle tissue‐specific *Tefm* knockout mice (*Tefm* ^*loxP*/*loxP*^, +/*Ckmm‐cre*; L/L, cre). The *Tefm* and *Polrmt* double‐heterozygous knockout mice (*Tefm* ^+/−^, *Polrmt* ^+/−^) were obtained by intercrossing *Tefm* ^+/*−*^ with heterozygous *Polrmt* knockout mice (*Polrmt* ^+/−^) [11](#embr201948101-bib-0011){ref-type="ref"}. All the mice strains used in this study are listed in [Table EV2](#embr201948101-sup-0004){ref-type="supplementary-material"}.

All mice in this study had an inbred C57BL/6N background. Animal studies were approved by the animal welfare ethics committee and performed in compliance with National and European law.

Method details {#embr201948101-sec-0016}
--------------

### Morphological analysis {#embr201948101-sec-0017}

Hearts collected from 8‐week‐old mice were fixed in 4% paraformaldehyde (PFA) at 4°C for 24 h. Then, the hearts were processed routinely and embedded in paraffin and sectioned to 5 μm thickness. Hematoxylin and eosin was performed for structural analysis.

### Transmission electron microscopy {#embr201948101-sec-0018}

Left myocardium was cut into small pieces and fixed in 2% glutaraldehyde, 0.5% paraformaldehyde, 0.1 M sodium cacodylate, 0.1 M sucrose, and 3 mM CaCl~2~, pH 7.4 at room temperature for 30 min, followed by 24 h at 4°C. Specimens were rinsed in a buffer containing 0.15 M sodium cacodylate and 3 mM CaCl~2~, pH 7.4; postfixed in 2% osmium tetroxide, 0.07 M sodium cacodylate, 1.5 mM CaCl~2~, pH 7.4 at 4°C for 2 h; dehydrated in ethanol followed by acetone; and embedded in LX‐112 (Ladd Research Industries). Ultra‐thin sections (40--50 nm) from longitudinal parts were cut and examined in a transmission electron microscope (Tecnai 10; FEI) at 80 kV. Digital images at a final magnification of 8,200× were randomly taken on myofibrils from sections of the myocardium.

### Crude mitochondrial isolation {#embr201948101-sec-0019}

Mitochondria from mouse heart were isolated as described previously [49](#embr201948101-bib-0049){ref-type="ref"}, using mitochondrial isolation buffer (320 mM sucrose, 10 mM Tris--HCl, pH 7.4, and 1 mM EDTA), supplemented with protease inhibitor (Roche) by differential centrifugation. Briefly, hearts were homogenized using Potter‐Homogenizer on ice (20 strokes, 500 rpm). Nuclei and cell debris were pelleted at 1,000 *g* for 10 min at 4°C. Next, the supernatant was centrifuged at 10,000 *g* for 10 min at 4°C. The differential centrifugation was repeated twice to obtain the crude mitochondria.

### Western blot analysis {#embr201948101-sec-0020}

50--100 μg of crude mitochondria were resuspended in 1× NuPAGE™ LDS Sample Buffer. Mitochondrial proteins were then separated by SDS--PAGE (4--12% Bis‐Tris Protein Gels; Invitrogen) and transferred onto polyvinylidene difluoride (PVDF) membranes (Merck Millipore). Immunoblotting was performed using standard procedures and developed using ECL reagent. The antibodies used in this study are listed in the [Table EV2](#embr201948101-sup-0004){ref-type="supplementary-material"}.

### RT--qPCR and northern blot analysis {#embr201948101-sec-0021}

For RT--qPCR, northern blotting, and 3′ RACE, total RNA was extracted from heart using Trizol reagent (Invitrogen) according to the manufacturer\'s instructions and then treated with TURBO DNA‐free™ DNase (Invitrogen). For RT--qPCR expression analysis, cDNA was reversed transcribed from 1 μg total RNA using High‐Capacity cDNA Reverse Transcription Kit (Invitrogen). The qPCR was performed in a QuantStudio 6 Flex Real‐Time PCR System (Life Technologies), using TaqMan™ Universal Master Mix II, with UNG (Applied Biosystems) to quantify mitochondrial transcripts (mt‐rRNAs and mt‐mRNAs), *Tefm*,*Actin*, and *18S*.

For RT--qPCR detection of transcripts across the tRNA‐mRNA junctions, H‐strand cDNA was generated by reverse transcriptase PCR using High‐Capacity cDNA Reverse Transcription Kit; however, synthesized reverse primers, including Anti‐mt‐tRNA^C^‐R or Anti‐*Nd6*‐R and Actin‐R, were used instead of commercial random primers. Then, qPCR was performed using Platinum SYBR Green qPCR supermix‐UDG (Invitrogen) to quantify the transcripts containing tRNA‐mRNA junctions. Primer pair 1 (mt‐tRNA^A^‐F and Anti‐mt‐tRNA^C^‐R) was used to detect the antisense transcript of mt‐tRNAs cluster on the H strand, shown in Fig [5](#embr201948101-fig-0005){ref-type="fig"}B. Primer pair 2 (*Nd5*‐F and Anti‐*Nd6*‐R) was used to detect the *Nd5*‐antisense *Nd6* junction on the H strand, shown in Fig [5](#embr201948101-fig-0005){ref-type="fig"}C. *Actin* was used as endogenous control.

For northern blotting, 3 μg of total RNA was separated in either 1% MOPS--formaldehyde agarose gels to detect mt‐mRNAs and mt‐rRNAs or neutral 10% polyacrylamide gel to detect mt‐tRNAs, *7S RNA*, and unprocessed mtRNA intermediates. Separated RNAs were then transferred to Hybond‐N+ membranes (GE Healthcare) and hybridized with (i) randomly \[^32^P\] dCTP‐labeled dsDNA probes, following the Prime‐It II Random Primer Labeling Kit (Agilent), to detect mt‐mRNAs (except *Nd6*), mt‐rRNAs, *18S rRNA*,*5S rRNA*, and *5.8S rRNA*; (ii) *in vitro* transcribed single‐stranded \[^32^P\] UTP‐labeled RNA probe for *Nd6*, using the Riboprobe Combination System‐SP6/T7 RNA Polymerase (Promega); (iii) strand‐specific oligonucleotide probes labeled with \[^32^P\] dATP, using T4 Polynucleotide Kinase (New England Biolabs), to detect mt‐tRNAs, *7S RNA*, and unprocessed mtRNA intermediates. Radioactive signals were captured in a PhosphorImager screen and was quantified using a Typhoon 7000 FLA and the ImageQuant TL 8. 1 software (GE Healthcare). All the Taqman probes and the primer sequences are listed in the [Table EV2](#embr201948101-sup-0004){ref-type="supplementary-material"}.

### 3′ RACE {#embr201948101-sec-0022}

For rapid amplification of 3′ cDNA ends (3′ RACE), a phosphorylated oligonucleotide linker was first ligated to 2.5 μg of a total RNA using T4 RNA ligase 1 (New England Biolabs). RNA was precipitated and cDNA synthesized using the GeneAmp RNA PCR kit and a primer complementary to the linker sequence (anti‐linker). The cDNA was then amplified by PCR using the anti‐linker primer and a forward primer corresponding to the first 45 nucleotides from the transcription initiation site at LSP. PCR products were cloned into pCRII‐TOPO using TOPO TA Cloning Kit (Invitrogen), following manufacturer\'s instructions, and direct sequencing of the plasmid from single colonies was performed using M13 forward and M13 reverse primers. Sequence details are listed in [Table EV1](#embr201948101-sup-0003){ref-type="supplementary-material"}.

### DNA isolation and mtDNA quantification {#embr201948101-sec-0023}

Genomic DNA from mouse heart was isolated with the DNeasy Blood and Tissue Kit (Qiagen) following manufacturer\'s instructions, followed by treatment with RNase A. mtDNA was measured by quantitative PCR using 5 ng of DNA in a QuantStudio 6 Flex Real‐Time PCR System using TaqMan™ Universal Master Mix II, with UNG. The TaqMan assays were used for the detection of mtDNA, which were *Nd1*,*Nd6*, and *Cyb*. *18S* was used to normalize for nuclear input. Three technical replicates were performed.

### Southern blot analysis and D‐loop Southern {#embr201948101-sec-0024}

For Southern blot analysis, 3 μg of DNA samples was digested with SacI to linearize mtDNA molecules, followed by separation on a 0.8% agarose gel and blotted to Hybond‐N+ membranes. The D‐loop was assessed as described previously [11](#embr201948101-bib-0011){ref-type="ref"}, and mtDNA was isolated by phenol/chloroform extraction from purified mitochondria. Samples were heated for 3 min at 100°C before loading. Membranes were hybridized with \[^32^P\] dCTP‐labeled dsDNA probes following the Prime‐It II Random Primer Labeling Kit to detect total mtDNA (pAM1), the D‐loop, or nuclear DNA (18S rDNA) as loading control and exposed to PhosphorImager screens.

### In *organello* transcription assay {#embr201948101-sec-0025}

*In organello* transcription assay was performed on crude mitochondria isolated from mouse hearts. 750 μg of mitochondria was washed three times with 500 μl of cold incubation buffer (25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 10 mM K~2~HPO~4~, 50 μM EDTA, 5 mM MgCl~2~, 1 mM ADP, 10 mM glutamate, 2.5 mM malate, 10 mM Tris--HCl, pH 7.4, and 1 mg/ml BSA). Mitochondria were pelleted by centrifugation, resuspended in 500 μl of transcription labeling buffer supplemented with 40 μCi of \[^32^P\] UTP, and gently rotated for 1 h at 37°C. After incubation, mitochondria were washed with 500 μl of washing buffer (10% glycerol, 10 mM Tris--HCl, pH 6.8, and 0.15 mM MgCl~2~) and RNA was isolated with Trizol reagent (Invitrogen), following the manufacturer\'s instructions. An aliquot of the labeled mitochondria was used for western blot analysis to ensure equal input of mitochondrial extracts. The isolated RNA was analyzed by northern blotting, as described before.

### In *organello* replication assay {#embr201948101-sec-0026}

*In organello* replication assay was performed on crude mitochondria isolated from mouse hearts. 750 μg of isolated mitochondria was washed three times with 500 μl of incubation buffer and resuspended in 500 μl of incubation buffer supplemented with 50 μM dCTP, 50 μM dTTP, 50 μM dGTP, and 20 μCi of \[^32^P\] dATP, and incubated for 2 h at 37°C. After incubation, mitochondria were washed three times in washing buffer. An aliquot of the labeled mitochondria was used for western blot analysis to ensure equal input of mitochondrial extracts. Then, mtDNA was isolated by phenol/chloroform extraction using standard procedures, and radiolabeled replicated DNA was analyzed by Southern blotting, as described previously.

### Measurement of mitochondrial respiration {#embr201948101-sec-0027}

To obtain high‐quality crude mitochondria for respiration analysis, heart tissue was finely cut and digested with 0.2% trypsin in 2 ml mitochondrial isolation buffer (310 mM sucrose, 20 mM Tris--HCl, and 1 mM EGTA, pH 7.2) for 10 min at 4°C, with constant rotation. Heart tissue was gently hand‐homogenized with 5 ml ice‐cold mitochondrial isolation buffer. Mitochondria were purified by differential centrifugation, as previously described. Mitochondrial oxygen consumption flux was measured at 37°C using 25--50 μg of crude mitochondria diluted in 2.1 ml mitochondrial respiration buffer (120 mM sucrose, 50 mM KCl, 20 mM Tris--HCl, 4 mM KH~2~PO~4~, 2 mM MgCl~2~, and 1 mM EGTA, pH 7) within an Oxygraph‐2k chamber (Oroboros Instruments). The oxygen consumption rate was measured either using 10 mM pyruvate, 10 mM glutamate, and 5 mM malate or 10 mM succinate in the presence of 0.5 μM rotenone. The phosphorylating state was obtained using 2.5 mM ADP and the non‐phosphorylating state using 125 ng/ml oligomycin. Maximal mitochondrial respiration, uncoupling, was reached by successive addition of CCCP up to 0.3 μM.

### Blue native polyacrylamide gel electrophoresis {#embr201948101-sec-0028}

Crude heart mitochondria (65 μg) were solubilized in 16 μl of 1× NativePAGE sample buffer containing 1% *n*‐dodecyl‐β‐d‐maltoside (DDM) and incubated on ice for 15 min. Samples were then centrifuged at 20,000 *g* for 30 min at 4°C. Supernatant was collected, and 0.5 μl of NativePage 5% G‐250 sample additive was added to each sample. Next, proteins and high molecular weight native makers were separated on a 3--12% NativePage gel (Invitrogen) at 120V using a dark blue cathode (1× NativePAGE running buffer and 0.5× cathode additive) until the blue‐front migrated 50% of the gel followed by a light blue cathode buffer (1× NativePAGE running buffer and 0.1× cathode additive). The anode buffer consisted of 1× NativePAGE running buffer. For western blot analysis, proteins were then blotted onto a PVDF membrane with transfer buffer (48 mM Tris and 39 mM glycine) for 1.5 h at 400 mA. Membranes were completely destained with methanol before proceeding with standard immunoblotting.

### Ultrapure mitochondria isolation {#embr201948101-sec-0029}

Ultrapure mitochondria were prepared as previously described [54](#embr201948101-bib-0054){ref-type="ref"}. Crude mitochondrial pellets from mouse hearts were washed in 1xM buffer (220 mM mannitol, 70 mM sucrose, 5 mM HEPES pH 7.4, 1 mM EGTA pH 7.4); pH was adjusted with potassium hydroxide, supplemented with EDTA‐free complete protease inhibitor cocktail and PhosSTOP Tablets (Roche), and purified on a Percoll density gradient (12%:19%:40% prepared with buffer 2xM) via centrifugation in a SW41 rotor at 41,086 *g* at 4°C for 1 h in a Beckman Coulter Optima L‐100 XP ultracentrifuge using 14 × 89 mm Ultra‐Clear Centrifuge Tubes (Beckman Instruments Inc.). Mitochondria were harvested at the interphase between 19 and 40%, and washed three times with buffer 1xM, and mitochondrial pellets were frozen at −80°C. Purified frozen mitochondria pellets were suspended in lysis buffer (6 M guanidinium chloride, 10 mM Tris(2‐carboxyethyl)phosphine hydrochloride, 40 mM chloroacetamide, and 100 mM Tris--HCl). After complete lysis, samples were diluted 1:10 in 20 mM Tris--HCL pH 8.0 and 80 μg of protein was mixed with 3 μg of Trypsin gold (Promega) and incubated overnight at 37°C to achieve complete digestion. Peptides were cleaned with home‐made STAGEtips [69](#embr201948101-bib-0069){ref-type="ref"} (Empore Octadecyl C18; 3M) and eluted in 60% acetonitrile/0.1% formic acid buffer. Samples were dried in a SpeedVac apparatus (Eppendorf concentrator plus 5305) at 45°C, and the peptides were suspended with 0.1% formic acid. Approximately 1.5 μg of peptides was analyzed by LC‐MS/MS.

### Label‐free quantitative proteomics {#embr201948101-sec-0030}

Peptides were separated on a 25 cm, 75 μm internal diameter PicoFrit analytical column (New Objective) packed with 1.9 μm ReproSil‐Pur media (Dr. Maisch) using an EASY‐nLC 1200 (Thermo Fisher Scientific). The column was maintained at 50°C. Buffer A was 0.1% formic acid in water; buffer B was 80% acetonitrile, 0.1% formic acid. Peptides were separated on a segmented gradient from 3 to 6% buffer B for 10 min, from 6 to 25% buffer B for 100 min, from 25 to 31% buffer B for 10 min, and from 31 to 60% buffer B for 10 min, at 200 nl/min. For the BioID experiment, peptides were separated on a segmented gradient from 6 to 31% buffer B for 80 min and from 31 to 50% buffer B for 10 min. Eluting peptides were analyzed on a QExactive HF mass spectrometer (mitoproteome quantification, Thermo Fisher Scientific) or Orbitrap Fusion (BioID experiment, Thermo Fisher Scientific). Peptide precursor mass to charge ratio (*m*/*z*) measurements (MS1) was carried out at 60,000× resolution, in the 300--1,800 *m*/*z* range. The top ten most intense precursors with charge state from 2 to 7 only were selected for HCD fragmentation using 25% normalized collision energy. The *m*/*z* of the peptide fragments (MS2) was measured at 30,000× resolution, using an AGC target of 2e5 and 80‐ms maximum injection time. Upon fragmentation, precursors were put on an exclusion list for 45 s.

### BioID {#embr201948101-sec-0031}

TEFM‐BirA\*‐HA and MTS‐BirA\*‐HA (mitochondrial targeting sequence from human COX8a) were cloned into pcDNA5/FRT/TO vector. Human Flp‐In T‐REx 293 cells were nucleofected using NucleofectorTM Lonza device. Cells were seeded in DMEM GlutaMax and supplemented with 10% FBS and 1% pen/strep (100 U/ml). The next day, 200,000 cells were collected and resuspended in 20 μl of Nucleofector™ Solution with 900 ng of pOG44 and 100 ng of construct. 24 h after nucleofection, cells were passaged into 10‐cm^2^ plates and selected by the addition of hygromycin and blasticidin at final concentration of 100 and 10 μg/ml, respectively. This selection medium was changed every 2--3 days until clear visible colonies were present. Several colonies per construct were picked and expanded. Selected clones were scaled up to one 245 × 245 × 25 mm^3^ square dish for treatment and harvesting. The cells were induced with 1 μg/μl of doxycycline at around 70% of confluency. The day after, cells were treated with 50 μM biotin for protein labeling. Cells were harvested 24 h later and washed three times with PBS by pelleting at 800 *g* for 5 min at 4 °C. Mitochondria were isolated using mitochondria isolation buffer (20 mM HEPES pH 7.6, 220 mM mannitol, 70 mM sucrose, 1 mM EDTA, 1× protease inhibitor, 2 mg/ml BSA) by differential centrifugation. The cells were homogenized in homogenizer by applying 15--20 strokes. This suspension was then centrifuged at 800 *g* for 5 min at 4°C. Collected supernatant was centrifuged at 10,000 *g* for 10 min at 4°C. Pellet (crude mitochondria) was then resuspended in mitochondria isolation buffer without BSA and centrifuged again at 10,000 *g* for 10 min at 4°C.

Pull‐down experiments were performed according to the published protocol [56](#embr201948101-bib-0056){ref-type="ref"} with small modifications. Mitochondrial pellet was lysed in 1 ml of lysis buffer (50 mM Tris--HCl, pH 7.4, 500 mM NaCl, 0.2% SDS, 1× protease inhibitor, 1 mM DTT). Subsequently, 20 μl of 20% Triton X‐100 was added. Samples were incubated for 30 min on ice and then centrifuged at 16,500 *g*, 4°C for 10 min. Dynabeads MyOne Streptavidin C1 (Thermo Fisher Scientific) were incubated with the lysates on a rotator at 4°C overnight. There were 9 following washing steps. Samples were eluted in elution buffer (2 M Urea, 5 ng/μl Trypsin, 1 mM TCEP, 50 mM Tris--HCl, pH 7.5) at room temperature. A volume of 5 mM CAA was added to the samples, and reaction was incubated at 37°C overnight. The samples were further analyzed by LC‐MS/MS mass spectrometry. The proteins of TEFM‐BioID are listed in [Dataset EV1](#embr201948101-sup-0005){ref-type="supplementary-material"}.

### LC‐MS/MS data analysis {#embr201948101-sec-0032}

The raw data were analyzed with MaxQuant [70](#embr201948101-bib-0070){ref-type="ref"} version 1.5.2.8 using the integrated Andromeda search engine [71](#embr201948101-bib-0071){ref-type="ref"}. Peptide fragmentation spectra were searched against the canonical and isoform sequences of the mouse reference proteome (proteome ID UP000000589, downloaded August 2015) or the human reference proteome (BioID experiment, proteome ID UP000005640, downloaded September 2018) from UniProt. The database was automatically complemented with sequences of contaminating proteins by MaxQuant. Methionine oxidation and protein N‐terminal acetylation were set as variable modifications. Digestion parameters were set to "specific" and "Trypsin/P", allowing for cleavage after lysine and arginine, also when followed by proline. The minimum number of peptides and razor peptides for protein identification was 1; the minimum number of unique peptides was 0. Protein identification was performed at a peptide spectrum matches and protein false discovery rate of 0.01. The "second peptide" option was on to identify co‐fragmented peptides. Successful identifications were transferred between the different raw files using the "Match between runs" option, using a match time window of 0.7 min. Label‐free quantification (LFQ) [72](#embr201948101-bib-0072){ref-type="ref"} was performed using an LFQ minimum ratio count of 2.

Analysis of the label‐free quantification results was performed with Perseus computation platform [73](#embr201948101-bib-0073){ref-type="ref"}, version 1.5.0.0 and R [74](#embr201948101-bib-0074){ref-type="ref"}. Proteins marked as "Reverse", "Only identified by site", and "Potential contaminant" were removed. LFQ intensity values were log~2~ transformed and proteins that contained at least three valid values in L/L or L/L, cre groups, and five valid values for the BioID experiment were kept for further analysis.

Missing values were imputed with a width of 0.3 and down shift of 1.8. Differential expression analysis was performed using the two‐sided moderated *t*‐test from the limma package [75](#embr201948101-bib-0075){ref-type="ref"}. Proteins with a Benjamini‐Hochberg adjusted *P* \< 0.05 were designated as differentially regulated. Differentially expressed proteins were manually classified into selected mitochondrial pathways.

### RNA sequencing analyses {#embr201948101-sec-0033}

RNA was isolated from total mouse heart and crude heart mitochondria using the miRNeasy Mini Kit (Qiagen), according to manufacturer\'s instructions. RNA quantity, purity, and integrity were verified using a Bioanalyzer.

#### TruSeq library analysis {#embr201948101-sec-0034}

Sequenced reads were aligned to the mouse genome reference sequence (mm10), masked for NUMTs regions, with bowtie2 v2.2.9 [76](#embr201948101-bib-0076){ref-type="ref"}, and the subsequent alignments filtered with SAMtools v.1.3.1 [77](#embr201948101-bib-0077){ref-type="ref"} (‐q 2 ‐f 2 ‐F 256) to retain mapped proper pairs and exclude secondary alignments and multireads (read alignments with equal primary and secondary alignment scores). Mitochondrial alignments were extracted, split by template strand, and converted to full‐length RNA fragment BED files, before coverage was calculated with BEDtools [78](#embr201948101-bib-0078){ref-type="ref"} genomecov (‐d ‐scale \[1e+06/total mapped reads\]), normalized to the total number of fragments mapped to the mouse whole genome (reads per million; RPM), and converted to wig format for visualization. Gene‐level counts for the nuclear genome were calculated with featureCounts [79](#embr201948101-bib-0079){ref-type="ref"} (‐s 2) using the GENCODE vM12 annotation (excluding mitochondrial annotations), while counts for mitochondrial genes were calculated with BEDtools coverage (‐counts ‐s ‐F 0.80) using a GENCODE‐based annotation with contiguous mt‐Atp8/6 and mt‐Nd4 l/4 intervals, and an approximate *7S RNA* annotation (chrM:16035‐16188). BEDtools coverage was used for mitochondrial genes due to their compact genomic organization and the subsequent overlapping of multiple genes by read alignments with post‐transcriptional 5′ or 3′ extensions, which is addressed by specifying a minimum 80% overlap between the read and the annotation. Count tables were collated in R v3.3.2 [74](#embr201948101-bib-0074){ref-type="ref"}, and differential expression between conditions was analyzed with DESeq2 v1.14.1 [80](#embr201948101-bib-0080){ref-type="ref"}.

#### Small RNA library analysis {#embr201948101-sec-0035}

Reads were trimmed of 3′ adapter sequences with cutadapt v1.10 [81](#embr201948101-bib-0081){ref-type="ref"} (‐m 15 ‐a TGGAATTCTCGGGTGCCAAGG). Trimmed reads were aligned to the mouse genome reference sequence (mm10), masked for NUMTs regions, with bowtie2 [76](#embr201948101-bib-0076){ref-type="ref"}, and the subsequent alignments filtered with SAMtools v1.3.1 [77](#embr201948101-bib-0077){ref-type="ref"} (‐q 2 ‐F 260) to exclude unmapped reads, secondary alignments, and multireads. Mitochondrial alignments were extracted and split by strand, and coverage was calculated with BEDtools [78](#embr201948101-bib-0078){ref-type="ref"} genomecov (‐d ‐scale \[1e+06/total mapped reads\]), normalized to the total number of mapped reads to the mouse whole genome (reads per million; RPM), and converted to wig format for visualization. Gene‐level counts for the nuclear genome were calculated with featureCounts [79](#embr201948101-bib-0079){ref-type="ref"} (‐s 1), while counts for mitochondrial genes were calculated with BEDtools coverage (‐counts ‐s ‐F 0.80). Count tables were collated in R v3.3.2 [74](#embr201948101-bib-0074){ref-type="ref"}, and differential expression between conditions was analyzed with DESeq2 v1.14.1 [80](#embr201948101-bib-0080){ref-type="ref"}.

Statistical analysis {#embr201948101-sec-0036}
--------------------

Experiments were performed at least three times, and results are representative of *n* \> 5 independent biological replicates, unless indicated otherwise. All values are expressed as means ± SEM. Statistical analysis of proteomics and RNA sequencing are described above. Other statistical analyses were conducted using GraphPad Prism 5 software. Statistical significance between two groups was assessed by two‐tailed unpaired Student\'s *t‐*test, and statistical significance between more than two groups was performed using one‐way analysis of variance (ANOVA). Differences were considered statistically significant at a value of *P* \< 0.05.
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